Task first
Define the decision, user, risk, and evidence before selecting a model or interface.
A model can perform well in a benchmark and still fail in your process. We evaluate the complete system—sources, prompts, tools, users, review steps, and operating context.
Our research posture is designed for pharmaceutical work, where a fluent answer is not enough. The system must be useful to qualified users, grounded in the intended evidence, and explicit about limitations.
Define the decision, user, risk, and evidence before selecting a model or interface.
Test missing data, disagreement, prompt injection, stale sources, and out-of-scope requests.
Keep sources, assumptions, uncertainty, and human actions connected to each output.
Useful evaluation is continuous but controlled. Representative issues become new test cases, approved changes move through a repeatable test process, and production monitoring identifies when re-evaluation is needed.
Include normal work, edge cases, high-risk scenarios, and known past failures.
Agree thresholds with domain experts and connect them to operational outcomes.
Evaluate retrieval, model output, tool use, interface behaviour, and escalation.
Record failures, root causes, changes, retest results, and the decision to proceed.
No single score describes whether an AI workflow is fit for purpose. The evaluation record combines technical, domain, and operational evidence.
Claims are supported by cited sources and do not overstate what the evidence shows.
Important evidence, limitations, conflicts, and unanswered questions are surfaced.
The response addresses the intended decision without irrelevant or duplicated material.
Source, configuration, model, and review information can be connected to the result.
The workflow behaves appropriately under adversarial input, failure, and conflicting evidence.
Expert review measures whether the system improves speed, consistency, confidence, or discovery.
Human review is part of evaluation. Expert reviewers assess the quality of the system, the evidence, and the final operating decision as separate but connected activities.
Review is not a final button added after generation. We define when a person must inspect sources, when a domain expert is required, when escalation is mandatory, and what evidence the reviewer needs to make the decision.
Data minimisation, source governance, and access controls are part of research design. The system should work within a defined evidence boundary rather than searching everything available.
Name authoritative corpora, document versions, data owners, and permitted uses.
Identify unapproved, personal, confidential, or out-of-scope information and test that it is not used.
Define how source freshness is shown and when an older document should block a recommendation.
Do not hide disagreement. Show source, date, context, and the reason for prioritisation.
This website describes intended capabilities and delivery principles. It does not claim that any specific model, workflow, or deployment is clinically validated, regulatory approved, or guaranteed to produce a particular business outcome. Those conclusions require defined evidence for the actual system and intended use.
Need an evaluation plan? Contact us to discuss a specific use case, evidence boundary, and risk profile.
We can help turn expert expectations and known failure modes into an evaluation plan your team can use.